APRETUDE 600 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADA
APRETUDE 600 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADA
Pending
Register Number
1231760002
Prescription Type
Diagnóstico Hospitalario
Authorization Date
Sep 22, 2023
Dosage Form
SUSPENSION INYECTABLE DE LIBERACION PROLONGADA
Route: VÍA INTRAMUSCULAR
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number1231760002
EMA Approved
Yes
Drug Classification
✗
Generic
No
✗
Orphan
No
✗
Biosimilar
No
✗
Commercialized
No
CIMA AEMPS Classification
INGREDIENTS (1)
CABOTEGRAVIRActive
Quantity: 600 mg
Name: CABOTEGRAVIR
ATC CLASSIFICATION (3)
J05A
J05AJ
J05AJ04